Healthcare -
Biotechnology - NASDAQ - US
$ 9.36
-1.06 %
$ 496 M
Market Cap
-4.5
P/E
STOK - SHORT-TERM DEBT
Short-term Debt STOK - Stoke Therapeutics, Inc.
2.39 M
LAST VALUE
25.88%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR